XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) EBITDA Margin (2020 - 2022)

Updated

XBiotech's EBITDA Margin came in at -794.91% for FY2022, down 672.95 percentage points from -121.96% in FY2021.

Analysis

XBiotech (XBIT) EBITDA Margin (2020 - 2022) Analysis & Trends

  • Per Business Quant, earlier years put EBITDA Margin at -121.96% in FY2021 (-85.51 pp) and -36.45% in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 32.68%
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 46.88%
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 40.75%
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 39.77%
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 46.62%
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 50.63%
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 42.49%
10 XBiotech 58.23 Mn -439.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -336.61%
Jun 30, 2022 -742.94%
Mar 31, 2022 -1,427.00%
Dec 31, 2021 -144.24%
Sep 30, 2021 -67.36%
Jun 30, 2021 -220.27%
Mar 31, 2021 -60.45%
Dec 31, 2020 -82.29%
Sep 30, 2020 -39.07%
Jun 30, 2020 -38.51%
Mar 31, 2020 -12.72%
API Access

XBiotech EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=XBIT&period=max&api_key=YOUR_API_KEY